The fund aims to build a portfolio of 20-25 companies that address gaps in services and products across pharmaceuticals, ...

While billions pour into pharmaceutical biotech, officials and experts warn there’s much less private investment in products more relevant to the military, like body armor materials, anti-corrosion ...

Curie.Bio, the biotech accelerator and investment firm, has raised another $340 million to invest in startups.

The portfolio will comprise 20-25 B2B startups spanning Pre-seed to Series A stages, addressing innovation gaps in areas such as pharmaceuticals, biotechnology, medical technology, specialty chemicals ...

More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

Diag-Nose.io hopes to transform management of chronic respiratory diseases globally using its AI-powered biomarker diagnostic ...

Here's how Winston Starts and Innovation Quarter's new partnership will help local biotech startups and benefit the local economy. Biotech startups in Winston-Salem have new opportunities for ...

A joint report by the Institute for Deep Tech Innovation (DEEP) at ESMT Berlin and the Bertelsmann Stiftung highlights Germany’s immense innovation potential in the biotech sector. However, this ...

A breakthrough CAR-T cell therapy, Qartemi, has been approved for blood cancer patients in India, offering new hope to those ...